MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 134 filers reported holding MERSANA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $166,040 | -76.7% | 130,740 | -39.7% | 0.00% | – |
| Q2 2023 | $713,009 | +74.0% | 216,720 | +117.4% | 0.00% | – |
| Q1 2023 | $409,767 | -29.9% | 99,700 | 0.0% | 0.00% | – |
| Q4 2022 | $584,242 | -13.3% | 99,700 | 0.0% | 0.00% | – |
| Q3 2022 | $674,000 | +62.4% | 99,700 | +10.9% | 0.00% | – |
| Q2 2022 | $415,000 | +34.7% | 89,900 | +16.3% | 0.00% | – |
| Q1 2022 | $308,000 | -35.8% | 77,300 | +0.3% | 0.00% | – |
| Q4 2021 | $480,000 | -29.3% | 77,100 | +7.1% | 0.00% | – |
| Q3 2021 | $679,000 | -30.6% | 72,000 | 0.0% | 0.00% | – |
| Q2 2021 | $978,000 | -16.1% | 72,000 | 0.0% | 0.00% | -100.0% |
| Q1 2021 | $1,165,000 | -44.1% | 72,000 | -8.0% | 0.00% | 0.0% |
| Q4 2020 | $2,084,000 | +42.9% | 78,300 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,458,000 | -19.4% | 78,300 | +1.3% | 0.00% | 0.0% |
| Q2 2020 | $1,809,000 | +696.9% | 77,300 | +98.2% | 0.00% | – |
| Q1 2020 | $227,000 | +202.7% | 39,000 | +197.7% | 0.00% | – |
| Q4 2019 | $75,000 | +257.1% | 13,100 | 0.0% | 0.00% | – |
| Q3 2019 | $21,000 | -60.4% | 13,100 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | -94.9% | 13,100 | -77.4% | 0.00% | -100.0% |
| Q2 2018 | $1,034,000 | – | 57,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RHO CAPITAL PARTNERS INC | 796,458 | $14,830,000 | 12.35% |
| Consonance Capital Management LP | 3,468,171 | $64,577,000 | 7.87% |
| Sarissa Capital Management LP | 2,837,000 | $52,824,000 | 6.22% |
| Bain Capital Life Sciences Investors, LLC | 3,445,667 | $64,158,000 | 5.98% |
| Ghost Tree Capital, LLC | 1,050,000 | $19,551,000 | 5.65% |
| NEA Management Company, LLC | 5,959,520 | $110,966,000 | 4.70% |
| Soleus Capital Management, L.P. | 393,041 | $7,318,000 | 3.88% |
| ACUTA CAPITAL PARTNERS, LLC | 667,500 | $12,429,000 | 3.38% |
| Avoro Capital Advisors LLC | 6,800,000 | $126,616,000 | 1.80% |
| FNY Investment Advisers, LLC | 199,800 | $3,720,000 | 1.57% |